Business

The soaring demand for weight loss and diabetes treatments has paved the way for Eli Lilly’s unprecedented success in the past year. With CFO Anat Ashkenazi at the helm, the pharmaceutical giant has managed to navigate the windfall in revenue generated by diabetes injection Mounjaro and obesity drug Zepbound. However, despite these accomplishments, Ashkenazi acknowledges
0 Comments
Disney and Pixar made a significant impact at the box office this past weekend with the debut of “Inside Out 2,” which brought in an estimated $155 million domestically. This marks the second-highest theatrical opening of an animated film, with the first film to achieve this milestone since Warner Bros.’ “Barbie.” Notably, Disney does not
0 Comments
Boeing’s Starliner capsule “Calypso” has recently undergone an unexpected extension in its stay at the International Space Station (ISS), doubling the original planned mission duration. Initially intended to be in space for nine days, the crew flight test mission now anticipates returning to Earth on June 22 after at least 17 days in space, as
0 Comments
The United Auto Workers President, Shawn Fain, is currently under investigation by a federal court-appointed watchdog named Neil Barofsky. The monitor is responsible for monitoring the union and eliminating corruption. The investigation revolves around allegations of Fain abusing his power as union president. Moreover, there are accusations that union leaders, including Fain, have obstructed the
0 Comments
A recent panel of independent advisors to the Food and Drug Administration recommended the approval of Eli Lilly’s Alzheimer’s drug donanemab. This comes as positive news for the more than 6 million Americans living with Alzheimer’s, as it would provide another treatment option for those suffering from the disease. The recommendation, if followed by the
0 Comments